日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer

BilT03:一项针对既往接受过治疗的晚期胆道癌患者的纳武利尤单抗联合5-氟尿嘧啶和脂质体伊立替康的1b/2期多中心试验

Sahai, Vaibhav; Griffith, Kent A; Lin, Bruce S; Soares, Heloisa P; Chandana, Sreenivasa R; Crysler, Oxana; Kumar-Sinha, Chandan; Enzler, Thomas; Dippman, Dominique; Gunchick, Valerie; Zalupski, Mark M

Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Devimistat联合吉西他滨和顺铂治疗胆道癌:临床前评估和Ib期多中心临床试验(BilT-04)

Mohan, Arathi; Griffith, Kent A; Wuchu, Fulei; Zhen, David B; Kumar-Sinha, Chandan; Crysler, Oxana; Hsiehchen, David; Enzler, Thomas; Dippman, Dominique; Gunchick, Valerie; Achreja, Abhinav; Animasahun, Olamide; Choppara, Srinadh; Nenwani, Minal; Chinnaiyan, Arul M; Nagrath, Deepak; Zalupski, Mark M; Sahai, Vaibhav